FineHeart S.A: FineHeart Breaks New Ground With Successful Removal of the ICOMS FLOWMAKER in a 90-day In-vivo Trial
Easy removal with a beating heart without damage to the myocardium 30 days after implantation
Normal heart functioning 60 days after explantation
Completely sealed operation with dedicated implant fixation system
Quick recovery and short hospital stay
Autonomy and free from complications or infection, or structural damage to the heart and vital organs
FineHeart S.A a preclinical medical device company that has developed the
ICOMS FLOWMAKER, an Implantable Cardiac Output Management System designed to address the unmet need of patients suffering from severe heart failure, today announced the successful, simple, and breakthrough implantation and removal of its device in a 90-day in-vivo trial.